- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 18, 2026 | 33.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 33.52M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 32.25M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $7.09K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$15.22K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.35K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $786 |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$720.95K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$618.54K |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$262.05K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$2.3M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $727.3K |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $619.33K |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $727.3K |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $619.33K |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.35K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $786 |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.35K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $786 |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $11.98K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $27.71K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$102.41K |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$935.46K |